Barclays’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$141K Sell
48,067
-61,965
-56% -$275K ﹤0.01% 3881
2025
Q4
$547K Buy
110,032
+110,031
+11,003,100% +$480K ﹤0.01% 3792
2025
Q3
$3 Sell
1
-1,715
-100% -$4.71K ﹤0.01% 5422
2025
Q2
$3.88K Sell
1,716
-34,585
-95% -$98.5K ﹤0.01% 4994
2025
Q1
$96.9K Sell
36,301
-17,172
-32% -$53.4K ﹤0.01% 4425
2024
Q4
$188K Buy
53,473
+5,818
+12% +$26.4K ﹤0.01% 4343
2024
Q3
$226K Buy
47,655
+35,832
+303% +$164K ﹤0.01% 4230
2024
Q2
$55.6K Buy
+11,823
New +$57K ﹤0.01% 4167
2020
Q2
Sell
-5,671
Closed -$37K 5489
2020
Q1
$37K Buy
5,671
+5,670
+567,000% +$54.8K ﹤0.01% 5385
2019
Q4
$0 Buy
+1
New +$21 ﹤0.01% 6301
2014
Q3
Sell
-19
Closed -$132K 7631
2014
Q2
$125K Buy
+19
New +$233K ﹤0.01% 5245
2014
Q1
Sell
-4
Closed -$98.3K 7062
2013
Q4
$74K Buy
+4
New +$70.2K ﹤0.01% 5896
2013
Q3
Sell
-2
Closed -$41.4K 6817
2013
Q2
$51K Buy
+2
New +$44.7K ﹤0.01% 6290

Other funds holding ACHV